Sign In
Get Clay Free →

Suggestions

    David A.

    Head of Oncology Pipeline & Hematology, Global Medical Affairs at Takeda Oncology

    David A. is a versatile drug development leader with a rich background spanning over two decades in Medical Affairs, R&D, portfolio strategy, business development, competitive intelligence, marketing, clinical development, and sales.

    He holds a Master of Business Administration from Duke University's Global business MBA program, a Doctor of Philosophy in Biology from UC San Diego, and a Bachelor of Science in Biology, Philosophy, and Neuroscience from Duke University.

    David A. has held key positions at prominent organizations such as Takeda Oncology, AbbVie, Pharmacyclics, Eli Lilly and Company, Allergan, and has also worked as an Education Consultant and in various research roles.

    With a strong academic foundation and extensive industry experience, he excels in bridging the gap between scientific breakthroughs and commercial success in the pharmaceutical sector, showcasing prowess as a cross-functional problem solver and a leader in the field of drug development.

    Highlights

    Jan 2 · Yahoo Finance
    Lilly to Participate in J.P. Morgan Healthcare Conference - Yahoo Finance
    Lilly to Participate in J.P. Morgan Healthcare Conference - Yahoo Finance
    Nov 3 · Yahoo Finance
    Q3 2023 Eli Lilly and Co Earnings Call - Yahoo Finance
    Q3 2023 Eli Lilly and Co Earnings Call - Yahoo Finance